Integra Historical Balance Sheet

IART Stock

USD 23.60 1.12 4.53%

Trend analysis of Integra LifeSciences Holdings balance sheet accounts such as Total Current Liabilities of 370.7 M or Total Stockholder Equity of 1.9 B provides information on Integra LifeSciences' total assets, liabilities, and equity, which is the actual value of Integra LifeSciences to its prevalent stockholders. By breaking down trends over time using Integra LifeSciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Integra LifeSciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Integra LifeSciences is a good buy for the upcoming year.

Integra LifeSciences Inventory

470.45 Million

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integra LifeSciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About Integra Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Integra LifeSciences at a specified time, usually calculated after every quarter, six months, or one year. Integra LifeSciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Integra LifeSciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Integra currently owns. An asset can also be divided into two categories, current and non-current.

Integra LifeSciences Balance Sheet Chart

At this time, Integra LifeSciences' Cash is comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 3.3 B in 2025, whereas Accumulated Other Comprehensive Income is likely to drop (14.3 M) in 2025.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity Property Plant And Equipment Net

Add Fundamental

Total Assets

Total assets refers to the total amount of Integra LifeSciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Integra LifeSciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Integra LifeSciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Integra LifeSciences Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Most accounts from Integra LifeSciences' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Integra LifeSciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integra LifeSciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	144.2M	176.3M	202.7M	212.9M
Total Assets	3.9B	3.8B	4.3B	4.6B

Other Current Liab Total Assets

Integra LifeSciences balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Short Long Term Debt Total	Common Stock Total Equity	Short Term Investments	Short Term Debt
Total Assets		0.97	0.96	0.98	0.95	0.95	0.86	0.88	0.81	1.0	-0.2	0.84	0.97	0.8	0.99	0.94	0.77	0.72	0.99	0.88	0.97	0.97	0.98	0.83	0.76	-0.01
Other Current Liab	0.97		0.97	0.92	0.89	0.96	0.78	0.84	0.77	0.97	-0.02	0.8	0.95	0.8	0.98	0.92	0.77	0.72	0.98	0.8	0.94	0.97	0.98	0.81	0.69	-0.02
Total Current Liabilities	0.96	0.97		0.91	0.87	0.94	0.74	0.85	0.83	0.95	-0.15	0.84	0.93	0.78	0.96	0.87	0.85	0.76	0.97	0.75	0.95	0.95	0.98	0.83	0.64	-0.04
Total Stockholder Equity	0.98	0.92	0.91		0.96	0.87	0.89	0.85	0.84	0.97	-0.27	0.87	0.94	0.79	0.93	0.93	0.73	0.73	0.94	0.9	0.97	0.93	0.92	0.81	0.77	0.01
Property Plant And Equipment Net	0.95	0.89	0.87	0.96		0.87	0.94	0.89	0.75	0.94	-0.19	0.79	0.92	0.71	0.92	0.97	0.65	0.58	0.92	0.95	0.93	0.88	0.9	0.73	0.82	-0.03
Net Debt	0.95	0.96	0.94	0.87	0.87		0.75	0.9	0.64	0.96	-0.06	0.67	0.96	0.75	0.98	0.9	0.71	0.64	0.98	0.77	0.87	0.97	0.98	0.78	0.66	-0.06
Retained Earnings	0.86	0.78	0.74	0.89	0.94	0.75		0.77	0.75	0.84	-0.25	0.8	0.79	0.54	0.83	0.9	0.6	0.35	0.82	0.98	0.88	0.75	0.81	0.58	0.91	-0.12
Accounts Payable	0.88	0.84	0.85	0.85	0.89	0.9	0.77		0.58	0.9	-0.24	0.61	0.94	0.68	0.88	0.88	0.54	0.59	0.88	0.79	0.81	0.87	0.88	0.71	0.58	-0.17
Cash	0.81	0.77	0.83	0.84	0.75	0.64	0.75	0.58		0.77	-0.38	1.0	0.69	0.6	0.76	0.68	0.8	0.63	0.77	0.74	0.9	0.73	0.77	0.69	0.68	0.01
Non Current Assets Total	1.0	0.97	0.95	0.97	0.94	0.96	0.84	0.9	0.77		-0.19	0.8	0.97	0.8	0.99	0.94	0.73	0.72	0.99	0.87	0.94	0.99	0.98	0.83	0.74	0.0
Non Currrent Assets Other	-0.2	-0.02	-0.15	-0.27	-0.19	-0.06	-0.25	-0.24	-0.38	-0.19		-0.35	-0.16	-0.14	-0.14	-0.07	-0.16	-0.2	-0.14	-0.24	-0.23	-0.18	-0.14	-0.21	-0.11	0.01
Cash And Short Term Investments	0.84	0.8	0.84	0.87	0.79	0.67	0.8	0.61	1.0	0.8	-0.35		0.71	0.6	0.79	0.73	0.8	0.61	0.8	0.79	0.92	0.75	0.8	0.69	0.74	0.0
Net Receivables	0.97	0.95	0.93	0.94	0.92	0.96	0.79	0.94	0.69	0.97	-0.16	0.71		0.83	0.96	0.94	0.69	0.73	0.96	0.8	0.91	0.96	0.96	0.82	0.63	-0.02
Common Stock Shares Outstanding	0.8	0.8	0.78	0.79	0.71	0.75	0.54	0.68	0.6	0.8	-0.14	0.6	0.83		0.77	0.77	0.6	0.86	0.78	0.55	0.76	0.81	0.76	0.9	0.36	0.24
Non Current Liabilities Total	0.99	0.98	0.96	0.93	0.92	0.98	0.83	0.88	0.76	0.99	-0.14	0.79	0.96	0.77		0.93	0.75	0.67	1.0	0.85	0.94	0.98	1.0	0.81	0.74	-0.02
Inventory	0.94	0.92	0.87	0.93	0.97	0.9	0.9	0.88	0.68	0.94	-0.07	0.73	0.94	0.77	0.93		0.65	0.56	0.93	0.89	0.92	0.89	0.91	0.72	0.75	-0.03
Other Current Assets	0.77	0.77	0.85	0.73	0.65	0.71	0.6	0.54	0.8	0.73	-0.16	0.8	0.69	0.6	0.75	0.65		0.62	0.77	0.54	0.84	0.71	0.78	0.65	0.6	-0.02
Other Stockholder Equity	0.72	0.72	0.76	0.73	0.58	0.64	0.35	0.59	0.63	0.72	-0.2	0.61	0.73	0.86	0.67	0.56	0.62		0.69	0.39	0.68	0.77	0.69	0.88	0.24	0.2
Total Liab	0.99	0.98	0.97	0.94	0.92	0.98	0.82	0.88	0.77	0.99	-0.14	0.8	0.96	0.78	1.0	0.93	0.77	0.69		0.84	0.94	0.98	1.0	0.82	0.73	-0.02
Property Plant And Equipment Gross	0.88	0.8	0.75	0.9	0.95	0.77	0.98	0.79	0.74	0.87	-0.24	0.79	0.8	0.55	0.85	0.89	0.54	0.39	0.84		0.87	0.79	0.82	0.61	0.91	-0.09
Total Current Assets	0.97	0.94	0.95	0.97	0.93	0.87	0.88	0.81	0.9	0.94	-0.23	0.92	0.91	0.76	0.94	0.92	0.84	0.68	0.94	0.87		0.9	0.94	0.78	0.77	-0.03
Intangible Assets	0.97	0.97	0.95	0.93	0.88	0.97	0.75	0.87	0.73	0.99	-0.18	0.75	0.96	0.81	0.98	0.89	0.71	0.77	0.98	0.79	0.9		0.98	0.85	0.65	0.02
Short Long Term Debt Total	0.98	0.98	0.98	0.92	0.9	0.98	0.81	0.88	0.77	0.98	-0.14	0.8	0.96	0.76	1.0	0.91	0.78	0.69	1.0	0.82	0.94	0.98		0.81	0.71	-0.05
Common Stock Total Equity	0.83	0.81	0.83	0.81	0.73	0.78	0.58	0.71	0.69	0.83	-0.21	0.69	0.82	0.9	0.81	0.72	0.65	0.88	0.82	0.61	0.78	0.85	0.81		0.49	0.26
Short Term Investments	0.76	0.69	0.64	0.77	0.82	0.66	0.91	0.58	0.68	0.74	-0.11	0.74	0.63	0.36	0.74	0.75	0.6	0.24	0.73	0.91	0.77	0.65	0.71	0.49		-0.12
Short Term Debt	-0.01	-0.02	-0.04	0.01	-0.03	-0.06	-0.12	-0.17	0.01	0.0	0.01	0.0	-0.02	0.24	-0.02	-0.03	-0.02	0.2	-0.02	-0.09	-0.03	0.02	-0.05	0.26	-0.12

Click cells to compare fundamentals

Integra LifeSciences Account Relationship Matchups

Integra LifeSciences balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	3.6B	3.8B	3.9B	3.8B	4.3B	4.6B
Other Current Liab	182.1M	198.3M	144.2M	176.3M	202.7M	212.9M
Total Current Liabilities	401.0M	340.0M	320.9M	307.0M	353.0M	370.7M
Total Stockholder Equity	1.5B	1.7B	1.8B	1.6B	1.8B	1.9B
Property Plant And Equipment Net	371.2M	396.2M	459.6M	496.4M	570.8M	599.4M
Net Debt	1.2B	1.1B	1.2B	1.4B	1.6B	1.7B
Retained Earnings	532.3M	698.6M	879.1M	946.9M	1.1B	1.1B
Accounts Payable	54.6M	61.8M	102.1M	92.3M	106.2M	111.5M
Cash	470.2M	513.4M	456.7M	276.4M	317.9M	333.8M
Non Current Assets Total	2.4B	2.6B	2.7B	2.7B	3.1B	3.3B
Non Currrent Assets Other	11.3M	10.0M	(510.2M)	27.5M	24.7M	26.0M
Cash And Short Term Investments	470.2M	513.4M	456.7M	309.1M	355.5M	373.2M
Net Receivables	225.5M	231.8M	263.5M	259.3M	298.2M	313.1M
Common Stock Shares Outstanding	85.2M	85.5M	83.5M	80.3M	92.4M	67.2M
Liabilities And Stockholders Equity	3.6B	3.8B	3.9B	3.8B	4.3B	4.6B
Non Current Liabilities Total	1.7B	1.8B	1.8B	1.9B	2.2B	2.3B
Inventory	310.1M	317.4M	324.6M	389.6M	448.0M	470.5M
Other Current Assets	231.4M	91.1M	116.8M	100.0M	115.0M	120.8M
Other Stockholder Equity	1.1B	1.0B	914.1M	655.2M	753.5M	467.2M
Total Liab	2.1B	2.1B	2.1B	2.2B	2.5B	2.6B
Property Plant And Equipment Gross	371.2M	711.1M	789.3M	863.8M	993.4M	1.0B
Total Current Assets	1.2B	1.2B	1.2B	1.1B	1.2B	1.3B
Accumulated Other Comprehensive Income	(74.1M)	(45.2M)	10.3M	(15.1M)	(13.6M)	(14.3M)
Intangible Assets	989.4M	1.1B	1.1B	1.1B	1.2B	1.3B
Short Long Term Debt Total	1.7B	1.7B	1.6B	1.7B	1.9B	2.0B
Common Stock Total Equity	887K	893K	896K	905K	1.0M	528.7K
Short Term Investments	4.7M	12K	16.7M	32.7M	29.4M	30.9M
Short Term Debt	159.1M	74.6M	67.4M	29.8M	34.3M	32.6M
Common Stock	893K	896K	905K	909K	1.0M	547.5K
Other Liab	116.1M	131.2M	135.9M	201.8M	232.1M	243.7M
Other Assets	27.3M	168.6M	3.8B	63.2M	72.6M	69.0M
Long Term Debt	1.4B	1.4B	1.3B	1.5B	1.7B	1.8B
Treasury Stock	(119.9M)	(235.1M)	(234.4M)	(362.9M)	(326.6M)	(310.2M)
Property Plant Equipment	337.4M	287.5M	311.7M	311.3M	358.0M	375.9M
Current Deferred Revenue	5.3M	5.3M	7.3M	8.5M	9.8M	5.3M
Good Will	932.4M	1.0B	1.0B	1.1B	1.2B	1.3B
Net Tangible Assets	(569.1M)	(406.9M)	(474.2M)	(361.1M)	(325.0M)	(341.2M)
Retained Earnings Total Equity	398.6M	532.3M	698.6M	879.1M	1.0B	1.1B
Long Term Debt Total	1.2B	1.4B	1.4B	1.3B	1.5B	1.0B
Capital Surpluse	1.2B	1.3B	1.3B	1.3B	1.5B	1.0B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Integra Stock Analysis

When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Integra Historical Balance Sheet

Integra LifeSciences Inventory

470.45 Million

About Integra Balance Sheet Analysis

Integra LifeSciences Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Property Plant And Equipment Net

Integra LifeSciences balance sheet Correlations

Integra LifeSciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Integra LifeSciences balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Integra Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 1.0	Non Current Liabilities Total
Short Long Term Debt Total	+ 1.0	Non Current Liabilities Total
Short Long Term Debt Total	+ 1.0	Total Liab
Non Current Liabilities Total	+ 0.99	Total Assets

Non Currrent Assets Other	- 0.38	Cash
Cash And Short Term Investments	- 0.35	Non Currrent Assets Other
Non Currrent Assets Other	- 0.27	Total Stockholder Equity
Non Currrent Assets Other	- 0.25	Retained Earnings
Property Plant And Equipment Gross	- 0.24	Non Currrent Assets Other
Non Currrent Assets Other	- 0.24	Accounts Payable